Skip to content
Search AI Powered

Latest Stories

NBA's Kevin Durant Supports Cannabis

NBA great dedicated to normalization, legalization and social equity on multiple fronts.
NBA great dedicated to normalization, legalization and social equity on multiple fronts.


NBA star Kevin Durant likes cannabis, and he’s not afraid to tell the world.


According to Benzinga, Durant last year announced a partnership with marijuana investment company Canopy Rivers via his investment firm. He’s also supported Dutchie, a delivery service, according to the publication.



Now, Durant is becoming an advocate for cannabis use among NBA players and wants it to be taken off the banned substances list, according to the outlet.


In an episode of “All The Smoke,” which airs on Showtime, Durant said:

“It’s just like, marijuana is marijuana. It’s not harmful to anybody. It can only help and enhance and do good things. I feel like it shouldn’t even be a huge topic around it anymore.”

Kevin Durant


In a separate interview, NetsDaily.com reports Durant is dedicated to fighting stigma and supports social equity efforts to free incarcerated individuals with cannabis offenses.


“We start getting people out of jail for marijuana. That’s the next step,” he told the publication. “It’s a plant that’s put here for a reason, and that’s to bring us together. Hopefully it happens (removing marijuana from the banned substance list), especially in the NBA.”


For more on Durant’s thoughts of cannabis, read Benzinga’s full story here and NetsDaily.com’s latest here

More For You

Out-of-State Firms Dominate Kentucky's Marijuana Licenses - The Bluntness
Out-of-State Firms Dominate Kentucky's Marijuana Licenses - The Bluntness
Photo by Sander Sammy on Unsplash

Out-of-State Firms Rule KY's Marijuana Licenses

In Kentucky’s latest medical marijuana license lottery, out-of-state companies overwhelmingly came out on top again, leaving local businesses struggling to compete.

Following a trend that began with Kentucky’s cultivator and processor licenses in October, only one of the 36 businesses awarded dispensary licenses in November was entirely composed of Kentucky residents. Thirty-three winners had no prior ties to the state, raising concerns about fairness, economic benefits, and the dominance of out-of-state investors.

Keep ReadingShow less
a reaction to a great compliment
Why compliments matter.
Giphy

Compliments: The Power Move

There’s something oddly revolutionary about giving someone a compliment these days. Not the hollow, “Nice shirt, bro,” kind. I mean a real, unfiltered, bone-deep acknowledgment of something another human being is doing right. A small moment of connection that—let’s be honest—we’re all too stingy with.

And that’s a shame. Because in a world addicted to criticism and keyboard jockeys, the compliment is punk rock. It disrupts. It challenges cynicism. It rewires the way we see each other—and ourselves.

Keep ReadingShow less
FDA Approves Landmark Cannabis for PTSD in Veterans - The Bluntness

FDA Approves Landmark Cannabis for PTSD in Veterans - The Bluntness

Photo by Wesley Tingey on Unsplash

Landmark PTSD Cannabis OK

For years, military veterans suffering from post-traumatic stress disorder (PTSD) have sought alternative treatments beyond traditional pharmaceuticals. Now, after years of regulatory hurdles and advocacy, the U.S. Food and Drug Administration (FDA) has approved a groundbreaking Phase 2 clinical trial to study the effects of smoked marijuana on veterans with moderate to severe PTSD. Funded by tax revenue from Michigan's legal cannabis sales, this research represents a monumental step toward validating cannabis as a legitimate treatment option for PTSD.

PTSD affects millions of veterans, with many turning to medical marijuana for relief. Anecdotal evidence from veterans suggests that cannabis can alleviate anxiety, improve sleep, and reduce the emotional intensity of traumatic memories. Yet, despite its inclusion in many state-level medical marijuana programs, rigorous clinical data supporting its efficacy has been sparse.

Keep ReadingShow less
Differentiating Therapeutic Ketamine Use from Recreational Misuse - The Bluntness
A man in a white shirt is floating in the waterDifferentiating Therapeutic Ketamine Use from Recreational Misuse
Photo by thom masat on Unsplash

Ketamine's Duality: Integration is Key


In a 2019 New York Magazine article, a writer noted ketamine's rise in popularity among creative circles, positioning it as a trendy party drug. Ketamine, once confined to clinical settings, was now being used recreationally as a social enhancer.

Keep ReadingShow less
Mass Cannabis Regulators Finally Reveal What Social Consumption Will Look Like

Mass Cannabis Regulators Finally Reveal What Social Consumption Will Look Like

Photo by Siamak on Unsplash

Cannabis Regulators Unveil Plans

Three proposed license types include “Supplemental” for existing Marijuana Establishments, “Hospitality,” and “Event Organizer”

Up until this week, chatter about cannabis social consumption in Massachusetts had mostly been regressive. Instead of moving forward, news from the Cannabis Control Commission often indicated that the Bay State was no closer to having weed lounges than in 2018, when state lawmakers passed a bill with a provision to allow municipalities to permit such venues in accordance with particular rules.

We’ve covered that backstory extensively. But in light of a presentation on Social Consumption Establishments [SCEs] given today by CCC Commissioner Bruce Stebbins with supporting staff members, it’s finally time to look forward to social consumption, defined in Massachusetts as “A Marijuana Establishment licensed by the Commission where Consumers can purchase and safely consume Marijuana and Marijuana Products.”*

Keep ReadingShow less